← Back to news
Clinical trialUNITERAREFriday, April 3, 2026 · April 3, 2026

New Recruiting Trial: Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers

WHY IT MATTERS

If you have gastroesophageal cancer with brain metastases, this trial could help researchers understand why your cancer spread to the brain and potentially lead to more targeted treatment options in the future.

Researchers are looking for patients with gastroesophageal cancer (cancer of the food pipe and stomach) that has spread to the brain. This study will compare the genetic makeup of the original tumor with the cancer that spread to the brain to understand if they're the same or different. This information could help doctors choose better treatments for patients whose cancer has spread to the brain.

NCT ID: NCT07464470 Title: Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers Status: RECRUITING Sponsor: Blokhin's Russian Cancer Research Center Start date: 2026-04-01 URL: https://clinicaltrials.gov/study/NCT07464470 Source: UniteRare clinical trials database

ASK YOUR DOCTOR

Ask your oncologist if you meet the eligibility criteria for this trial and whether participating could be appropriate for your situation, especially if your gastroesophageal cancer has spread to the brain.

Find a specialist →Learn more ↗
clinical trialbrain metastasesgastroesophageal cancermolecular geneticsrecruiting

Related conditions

Hereditary gastric cancerGastric adenocarcinoma and proximal polyposis of the stomachHereditary diffuse gastric cancer